Literature DB >> 3193515

Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis.

L M Rainwater1, H Zincke.   

Abstract

A total of 30 patients underwent an operation (radical prostatectomy in 27 and cystoprostatectomy in 3) for prostate cancer. In 17 patients radiotherapy with curative intent (range 5,700 to 7,500 cGy., mean 6,130 cGy.) had failed locally at 7 to 150 months (mean 48.8 months) later; 13 underwent the operation 2 months or less after planned radiotherapy (4,000 to 7,000 cGy., mean 5,431 cGy.). Followup was 1 to 16 years (mean 6.7 years). There was no perioperative death. The most significant complications were vesical neck contracture (17 per cent), lymphedema (10 per cent) and incontinence (10 per cent). Pathological staging revealed 8 patients with stage D1 disease. Of tumor grade, stage, adjuvant hormonal treatment and ploidy pattern only the last was associated with progression and survival. An increasing number of patients with local, albeit often symptomatic, radiation failure may present during the next years and they must be treated. Salvage prostatectomy is feasible and its associated morbidity seems to be acceptable; alternative (nonoperative) treatment modalities have proved not to be effective. Deoxyribonucleic acid ploidy pattern can provide valuable prognostic information in this difficult patient population for decision-making regarding radical surgery and adjuvant hormonal treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193515     DOI: 10.1016/s0022-5347(17)42072-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?

Authors:  Stefano Arcangeli; Linda Agolli; Vittorio Donato
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-10

Review 2.  Assessment and therapy for voiding dysfunction after prostatectomy.

Authors:  Rodney A Appell
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

3.  [Pelvic laparoscopic lymphadenectomy after definitive radiotherapy of prostatic carcinoma].

Authors:  S Dinges
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

Review 4.  [Salvage radical prostatectomy].

Authors:  R E Hautmann
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

5.  Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer.

Authors:  Youness Ahallal; Shahrokh F Shariat; Daher C Chade; Clarisse Mazzola; Victor E Reuter; Jaspreet S Sandhu; Vincent P Laudone; Karim A Touijer; Bertrand D Guillonneau
Journal:  BJU Int       Date:  2010-12-16       Impact factor: 5.588

6.  Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene.

Authors:  A Tehranian; D W Morris; B H Min; D J Bird; R D Cardiff; P A Barry
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 7.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

Review 8.  Conservative management for postprostatectomy urinary incontinence.

Authors:  Coral A Anderson; Muhammad Imran Omar; Susan E Campbell; Kathleen F Hunter; June D Cody; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

Review 9.  Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.

Authors:  James S Rosoff; Stephen J Savage; Sandip M Prasad
Journal:  World J Urol       Date:  2013-01-29       Impact factor: 4.226

10.  Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Authors:  James L Mohler; Susan Halabi; Stephen T Ryan; Ali Al-Daghmin; Mitchell H Sokoloff; Gary D Steinberg; Ben L Sanford; James A Eastham; Philip J Walther; Michael J Morris; Eric J Small
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-11-01       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.